Exogenus Therapeutics CEO, Joana Simões Correia, is again an invited speaker at the 4th Exosome Based Therapeutic Development Summit, taking place in Boston, October 4th-6th. Joana’s talk will focus on the importance of EV quality control and on the therapeutic potential of Exo-101 in regenerative medicine and inflammatory conditions.

The event will focus on topics ranging from pre-clinical and clinical data, to EV characterization and large scale production, and will count with the participation of several companies working on EV therapeutics.

Referring to this year’s event, Joana Correia commented: “It is an immense honour to be invited once more to speak at this event, and to have the chance to hear about the latest breakthroughs other companies are having in the EV space. In the end, we all have the same goal: to reach patients in need as quickly as possible.”

Exogenus continues to develop Exo-101 for different applications, and is now also partnering with other companies to develop EV-based innovation.

To find out more about the full event and sign up to watch Joana’s talk, click here.